A detailed history of Bridgeway Capital Management, LLC transactions in Avita Medical, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 118,004 shares of RCEL stock, worth $442,515. This represents 0.01% of its overall portfolio holdings.

Number of Shares
118,004
Previous 37,600 213.84%
Holding current value
$442,515
Previous $198,000 202.53%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$4.17 - $6.76 $335,284 - $543,531
80,404 Added 213.84%
118,004 $599,000
Q2 2025

Aug 14, 2025

BUY
$4.77 - $10.25 $179,351 - $385,400
37,600 New
37,600 $198,000
Q4 2022

Feb 14, 2023

BUY
$4.53 - $7.55 $129,186 - $215,310
28,518 New
28,518 $188,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $93.9M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.